- Home
- VTVT vs PRE Comparison
VTVT vs PRE Comparison
Compare VTVT & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VTVT | PRE |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.0M | 131.3M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | VTVT | PRE |
|---|---|---|
| Price | $34.63 | $14.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $37.00 | $32.00 |
| AVG Volume (30 Days) | 12.6K | ★ 137.5K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $17,000.00 | ★ $77,079,000.00 |
| Revenue This Year | N/A | $219.28 |
| Revenue Next Year | N/A | $124.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 201.54 |
| 52 Week Low | $13.15 | $3.10 |
| 52 Week High | $35.95 | $17.99 |
Technical Indicators
Market Signals| Indicator | VTVT | PRE |
|---|---|---|
| Relative Strength Index (RSI) | 70.06 | 54.79 |
| Support Level | $22.92 | $12.93 |
| Resistance Level | $35.95 | $15.70 |
| Average True Range (ATR) | 2.23 | 1.14 |
| MACD | 0.59 | 0.10 |
| Stochastic Oscillator | 89.87 | 67.33 |
Price Performance
Historical ComparisonAbout VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin, currently in a Phase 3 trial, a potential novel first-in-class oral liver-selective glucokinase activator being investigated for the treatment of type 1 diabetes. The group and its development partners are investigating multiple molecules across different indications for chronic diseases. Its product pipeline are HPP737, Azeliragon, TTP-RA, TTP273, HPP971 / HPP3033, and HPP593.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.